Hyaluronic Acid Market, Trends & Analysis - Forecasts To 2026

1. Hyaluronic Acid Market, Trends & Analysis - Forecasts To 2026 By Application [Dermal Fillers, Osteoarthritis (Single Injection, Three- Injection, Five-Injection), Ophthalmic, Vesicoureteral Reflux], By Region (North America, Europe, Asia Pacific, Central & South America, Middle East & Africa); Vendor Landscape, and Company Market Share Analysis & Competitor Analysis Hyaluronic Acid Market Insights The Hyaluronic Acid market is projected to grow at a CAGR of 8.82% during the forecast period. The market is estimated to generate revenue of USD 16.2 Billion by 2026. Extensive use of hyaluronic acid in dermatology is expected to have a positive impact on the market. This growth can be attributed to growing number of people opting for aesthetic non-surgical procedures and growing geriatric population. Rising disposable income of individuals has led to consumers spending more on aesthetic non-surgical procedures such as hyaluronic acid injections. Factors such as high cost of the procedure and side-affects associated with hyaluronic acid are some factors expected to hinder the market up to a certain extent. Request for a free sample copy of this report @: https://www.globalmarketestimates.com/hyaluronic-acid-market/ Hyaluronic Acid Market: By Application The Hyaluronic Acid market can be segmented based on basis of application into dermal fillers, osteoarthritis, ophthalmic and vesicoureteral reflux among others. The osteoarthritis segment can be segmented further into single injection, three injections and five injections among others. The dermal fillers segment is expected to hold the largest market share in terms of revenue during the forecast period. Desire to look healthy and young and high effectiveness of dermal fillers is inclining men and women to opt for this procedure.

2. The osteoarthritis segment is also expected to grow at a substantial CAGR. Within the segment, the three injection segment is projected to hold the largest market share in terms of revenue, while the single injection segment is expected to grow at the highest CAGR. The ophthalmic applications segment is expected to grow at the fastest rate owing to growing incidence of cataract, glaucoma, dry eyes and age-related macular degeneration. Hyaluronic Acid Market: Regional Insights North America is expected to dominate the hyaluronic acid market, with U.S. being the major contributor. High disposable income of the population and their awareness about aging is expected to drive the market in the region. The Asia Pacific region is projected to register high growth rate in the coming years. Japan is expected to contribute a major share to the growth in Asia Pacific region due to its high geriatric population. Hyaluronic Acid Market: End-Use Landscape The end-use landscape entails a list of current and prospective consumers prevailing across the regions. This section provides company addresses, contact details, products, and regional presence of companies who are purchasing or are likely to purchase hyaluronic acid over the coming years. Some companies which are currently using hyaluronic acid and are likely to purchase it in future such as Shiseido, Proctor & Gamble Co and Unilever among others. Hyaluronic Acid Market: Vendor Landscape The report contains a chapter dedicated to vendors operating in the market, covering raw material manufactures, equipment developers, manufacturers, and distributors. The report provides these insights on a regional level. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence of companies. Hyaluronic Acid Market:Share & Competitor Analysis Some of the key players operating in the Hyaluronic Acid market areKikkoman, Allergan, Inc.; Sanofi (Genzyme); Salix Pharmaceuticals; Seikagaku Corporation; Galderma S.A., Zimmer Holdings, Inc.; Smith & Nephew Plc; Ferring Pharmaceuticals, Inc.; Anika Therapeutics, Inc.; and F. Hoffmann-La Roche Ltd.

3. In 2016, Genzyme Corporation received FDA approval for its single injection treatment. Presence of high-molecular weight polymers of hyaluronic acid in the product are used as a lubricant to reduce the pain caused by osteoarthritis. In March 2016, Anika Therapeutics launched its viscosupplement Cignal which is a combination of viscosupplement and steroids that help alleviate knee pain In 2015, Actavis acquired Allegran, which a manufacturer of hyarulonic acid based ophthalmic dermatologic and aesthetic products. Browse this report @: https://www.globalmarketestimates.com/hyaluronic-acid- market/